FY2025 · ended Sep 30, 2025 · Revenue $21.84B, +8.2% YoY · Filed Nov 25, 2025
Becton, Dickinson And Company (BDX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Sep 30, 2025, it reported revenue of $21.8 billion and net income of $1.7 billion. Free cash flow was $2.7 billion. As of Jun 30, 2026 it held $708.0 million in cash and investments and $13.5 billion in total debt.
Revenue (TTM)
$22.48B
+18.5% vs year-ago TTM
Net income (TTM)
$942.00M
-40.6% vs year-ago TTM
Operating cash flow (TTM)
$3.96B
+43.5% vs year-ago TTM
Free cash flow (TTM)
$3.20B
+54.2% vs year-ago TTM
EPS (TTM)
$3.33
-39.3% vs year-ago TTM
Dividend per share (TTM)
$4.19
+2.9% vs year-ago TTM
Shares outstanding
285.42M
-1.3% vs prior year
Net cash
$-12.80B
as of Jun 30, 2026
Operating margin
10.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BDX (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- NJ
- Headquarters
- Franklin Lakes, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 10795
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Sep 30, 2025 |
FY 2024 Sep 30, 2024 |
FY 2023 Sep 30, 2023 |
FY 2022 Sep 30, 2022 |
FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $21.8B | $20.2B | $19.4B | $18.9B | $19.1B |
| Operating income | $2.6B | $2.4B | $2.1B | $2.3B | $2.2B |
| Net income | $1.7B | $1.7B | $1.5B | $1.8B | $2.1B |
| Diluted EPS | $5.82 | $5.86 | $4.94 | $5.88 | $6.85 |
| Operating cash flow | $3.4B | — | — | — | — |
| Free cash flow | $2.7B | — | — | — | — |
| Total assets | $55.3B | $57.3B | $52.8B | $52.9B | $53.9B |
| Stockholders' equity | $25.4B | $25.9B | $25.8B | $25.3B | $23.7B |
| Cash and investments | $641.0M | $1.7B | $1.4B | $1.0B | $2.3B |
| Total debt | $18.5B | $18.7B | $15.3B | $14.4B | $17.6B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 22, 2026 | Jul 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 29, 2026 | May 29, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 20, 2026 | May 20, 2026 |
All 1003 Becton, Dickinson And Company SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.